1 |
LICHTENBERGER F B, PATZAK A. AKI and CKD[J]. Acta Physiol (Oxf), 2021, 232(2): e13646.
|
2 |
LEVEY A S. Defining AKD: the spectrum of AKI, AKD, and CKD[J]. Nephron, 2022, 146(3): 302-305.
|
3 |
KELLUM J A, ROMAGNANI P, ASHUNTANTANG G,et al. Acute kidney injury[J]. Nat Rev Dis Primers, 2021, 7(1): 52-65.
|
4 |
ORIEUX A, BOYER A, DEWITTE A, et al. Acute kidney injury in intensive care unit: a review[J]. Nephrol Ther, 2022, 18(1): 7-20.
|
5 |
KELLUM J A, WEN X Y, DE CAESTECKER M P, et al. Sepsis-associated acute kidney injury: a problem deserving of new solutions[J]. Nephron, 2019, 143(3): 174-178.
|
6 |
WANG Z, GU Z Y, HOU Q, et al. Zebrafish GSDMEb cleavage-gated pyroptosis drives septic acute kidney injury in vivo [J]. J Immunol, 2020, 204(7): 1929-1942.
|
7 |
JIANG S Q, ZHANG H, LI X, et al. Vitamin D/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3/caspase-1/GSDMD pyroptosis pathway[J]. J Steroid Biochem Mol Biol, 2021, 206: 105789.
|
8 |
XIAO C C, ZHAO H J, ZHU H, et al. Tisp40 induces tubular epithelial cell GSDMD-mediated pyroptosis in renal ischemia-reperfusion injury via NF-κB signaling[J]. Front Physiol, 2020, 11: 906.
|
9 |
HU Z X, ZHANG H, YI B, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis[J]. Cell Death Dis, 2020, 11(1): 73.
|
10 |
GRANATA S, VOTRICO V, SPADACCINO F,et al. Oxidative stress and ischemia/reperfusion injury in kidney transplantation: focus on ferroptosis, mitophagy and new antioxidants[J]. Antioxidants (Basel), 2022, 11(4): 769.
|
11 |
HEPOKOSKI M, SINGH P. Mitochondria as mediators of systemic inflammation and organ cross talk in acute kidney injury[J]. Am J Physiol Renal Physiol, 2022, 322(6): F589-F596.
|
12 |
STASI A, INTINI A, DIVELLA C, et al. Emerging role of Lipopolysaccharide binding protein in sepsis-induced acute kidney injury[J]. Nephrol Dial Transplant, 2017, 32(1): 24-31.
|
13 |
罗晓琴, 晏 萍, 张宁雅, 等. 危重症患者脓毒症急性肾损伤后的早期恢复模式与预后[J].中南大学学报(医学版),2022,47(5):535-545.
|
14 |
ALLISON S J. Acute kidney injury: mechanism of AKI sensitivity in diabetic nephropathy[J]. Nat Rev Nephrol, 2014, 10(9): 484.
|
15 |
LI Y F, REN K. The mechanism of contrast-induced acute kidney injury and its association with diabetes mellitus[J]. Contrast Media Mol Imaging, 2020, 2020: 3295176.
|
16 |
BELAVGENI A, MEYER C, STUMPF J, et al. Ferroptosis and necroptosis in the kidney[J]. Cell Chem Biol, 2020, 27(4): 448-462.
|
17 |
HU Z X, ZHANG H, YANG S K, et al. Emerging role of ferroptosis in acute kidney injury[J]. Oxid Med Cell Longev, 2019, 2019: 8010614.
|
18 |
ROELANDS J, GARAND M, HINCHCLIFF E,et al. Long-chain acyl-CoA synthetase 1 role in sepsis and immunity: perspectives from a parallel review of public transcriptome datasets and of the literature[J]. Front Immunol, 2019, 10: 2410.
|
19 |
MA F, ZOU Y L, MA L F, et al. Evolution, characterization, and immune response function of long-chain acyl-CoA synthetase genes in rainbow trout (Oncorhynchus mykiss) under hypoxic stress[J]. Comp Biochem Physiol B Biochem Mol Biol, 2022, 260: 110737.
|
20 |
YAN S, YANG X F, LIU H L, et al. Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update[J]. World J Gastroenterol, 2015, 21(12): 3492-3498.
|
21 |
MCCULLOUGH K, BOLISETTY S. Ferritins in kidney disease[J].Semin Nephrol,2020,40(2):160-172.
|
22 |
QU X F, LIANG T Y, WU D G, et al. Acyl-CoA synthetase long chain family member 4 plays detrimental role in early brain injury after subarachnoid hemorrhage in rats by inducing ferroptosis[J]. CNS Neurosci Ther, 2021, 27(4): 449-463.
|
23 |
徐 硕, 李 华. 酰基辅酶A合成酶长链家族成员4介导的脂质过氧化导致乳腺癌细胞发生铁死亡[J]. 成都医学院学报, 2020, 15(5): 545-551, 566.
|
24 |
WANG Y, ZHANG M H, BI R, et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury[J]. Redox Biol, 2022, 51: 102262.
|
25 |
YANG X D, YANG Y Y. Ferroptosis as a novel therapeutic target for diabetes and its complications[J]. Front Endocrinol (Lausanne), 2022, 13: 853822.
|
26 |
MARTÍN-SAIZ L, GUERRERO-MAUVECIN J, MARTÍN-SANCHEZ D, et al. Ferrostatin-1 modulates dysregulated kidney lipids in acute kidney injury[J]. J Pathol, 2022, 257(3): 285-299.
|
27 |
HU Z X, ZHANG H, YI B, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis[J]. Cell Death Dis, 2020, 11(1): 73.
|
28 |
LU H Y, SUN X F, JIA M, et al. Rosiglitazone suppresses renal crystal deposition by ameliorating tubular injury resulted from oxidative stress and inflammatory response via promoting the Nrf2/HO-1 pathway and shifting macrophage polarization[J]. Oxid Med Cell Longev, 2021, 2021: 5527137.
|
29 |
WANG W W, LIU Y L, WANG M Z, et al. Inhibition of renal tubular epithelial mesenchymal transition and endoplasmic reticulum stress-induced apoptosis with Shenkang injection attenuates diabetic tubulopathy[J]. Front Pharmacol, 2021, 12: 662-706.
|
30 |
孙 林, 庞 博, 佟 雪, 等. 腹膜透析相关腹膜血管新生的研究进展[J].中国实用内科杂志,2021,41(6):550-553.
|
31 |
谷名晓, 江 璐, 刘选成. 罗格列酮对大鼠急性肾损伤的保护作用及机制探讨[J]. 山东医药, 2014, 54(27): 41-43.
|
32 |
魏 啸, 付 林, 博庆丽, 等. 罗格列酮对细菌脂多糖诱发小鼠肾脏氧化应激的抑制效应[J]. 中华疾病控制杂志, 2020, 24(5): 597-601.
|